GPER1 and metabolic dysfunction-associated steatotic liver disease: Based on the findings that GPER1 acts a crucial role in the protective effects of estrogen on obesity, insulin resistance, hepatic lipid accumulation, and inflammatory response, we speculated that hepatic GPER1 may be involved in the progression of NAFLD.